Effect of anti-PcrV antibody in a murine chronic airway Pseudomonas aeruginosa infection model

European Respiratory Journal

Volumn 29, Issue 5, 2007, Pages 965-968

  Imamura, Y ^a   Yanagihara, K ^a   Fukuda, Y ^a   Kaneko, Y ^a   Seki, M ^a   Izumikawa, K ^a   Miyazaki, Y ^a   Hirakata, Y ^a   Sawa, T ^b   Wiener Kronish, J P ^b   Kohno, S ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Anti PcrV antibody; Chronic airway infection; Pseudomonas aeruginosa; Type III secretion system

Indexed keywords

IMMUNOGLOBULIN G; INTERLEUKIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 2; TUMOR NECROSIS FACTOR ALPHA; VIRULENCE FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; BACTERIAL VIRULENCE; BACTERICIDAL ACTIVITY; CELL COUNT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE MODEL; ENZYME LINKED IMMUNOSORBENT ASSAY; INHIBITION KINETICS; LUNG LAVAGE; MALE; MICROBIOLOGICAL EXAMINATION; MOUSE; NEUTROPHIL COUNT; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; PSEUDOMONAS AERUGINOSA; RESPIRATORY TRACT INFECTION; TREATMENT OUTCOME;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL TOXINS; BRONCHOALVEOLAR LAVAGE FLUID; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNOGLOBULIN FAB FRAGMENTS; IMMUNOGLOBULIN G; MALE; MICE; PORE FORMING CYTOTOXIC PROTEINS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RESPIRATORY TRACT INFECTIONS;

EID: 34248201529     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.00147406     Document Type: Article

References (15)

1. Kulich SM, Yahr TL, Mende-Mueller LM, Barbieri JT, Frank DW. Cloning the structural gene for the 49-kDa form of exoenzyme S (exoS) from Pseudomonas aeruginosa strain 388. J Biol Chem 1994; 269: 10431-10437.
2. Yahr TL, Barbieri JT, Frank DW. Genetic relationship between the 53- and 49-kilodalton forms of exoenzyme S from Pseudomonas aeruginosa. J Bacteriol 1996; 178: 1412-1419.
3. Finck-Barbancon V, Goranson J, Zhu L, et al. ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injury. Mol Microbiol 1997; 25: 547-557.
4. Yahr TL, Vallis AJ, Hancock MK, Barbieri JT, Frank DW. ExoY, an adenylate cyclase secreted by the Pseudomonas aeruginosa type III system. Proc Natl Acad Sci USA 1998; 95: 13899-13904.
5. Kudoh I, Wiener-Kronish JP, Hashimoto S, Pittet JF, Frank D. Exoproduct secretions of Pseudomonas aeruginosa strains influence severity of alveolar epithelial injury. Am J Physiol 1994; 267: L551-L556.
6. Sawa T, Ohara M, Kurahashi K, et al. In vitro cellular toxicity predicts Pseudomonas aeruginosa virulence in lung infections. Infect Immun 1998; 66: 3242-3249.
7. Sawa T, Yahr TL, Ohara M, et al. Active and passive immunization with the Pseudomonas V antigen protects against type III intoxication and lung injury. Nat Med 1999; 5: 392-398.
8. 2 in sepsis associated with Pseudomonas aeruginosa. J Immunol 2001; 167: 5880-5886.
9. Fleiszig SM, Zaidi TS, Fletcher EL, Preston MJ, Pier GB. Pseudomonas aeruginosa invades corneal epithelial cells during experimental infection. Infect Immun 1994; 62: 3485-3493.
10. Yanagihara K, Tomono K, Sawai T, et al. Effect of clarithromycin on lymphocytes in chronic respiratory Pseudomonas aeruginosa infection. Am J Respir Crit Care Med 1997; 155: 337-342.
11. Kaneko Y, Yanagihara K, Seki M, et al. Clarithromycin inhibits overproduction of muc5ac core protein in murine model of diffuse panbronchiolitis. Am J Physiol Lung Cell Mol Physiol 2003; 285: L847-L853.
12. Roy-Burman A, Savel RH, Racine S, et al. Type III protein secretion is associated with death in lower respiratory and systemic Pseudomonas aeruginosa infections. J Infect Dis 2001; 183: 1767-1774.
13. Courtney JM, Ennis M, Elborn JS. Cytokines and inflammatory mediators in cystic fibrosis. J Cyst Fibros 2004; 3: 223-231.
14. Bonfield TL, Panuska JR, Konstan MW, et al. Inflammatory cytokines in cystic fibrosis lungs. Am J Respir Crit Care Med 1995; 152: 2111-2118.
15. Mukae H, Kadota J, Ashitani J, et al. Elevated levels of soluble adhesion molecules in serum of patients with diffuse panbronchiolitis. Chest 1997; 112: 1615-1621.